chr19-41220662-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021913.5(AXL):c.112G>A(p.Val38Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,598,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021913.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AXL | NM_021913.5 | c.112G>A | p.Val38Met | missense_variant | 2/20 | ENST00000301178.9 | |
AXL | NM_001699.6 | c.112G>A | p.Val38Met | missense_variant | 2/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AXL | ENST00000301178.9 | c.112G>A | p.Val38Met | missense_variant | 2/20 | 1 | NM_021913.5 | A2 | |
AXL | ENST00000359092.7 | c.112G>A | p.Val38Met | missense_variant | 2/19 | 1 | P2 | ||
AXL | ENST00000599659.5 | n.126G>A | non_coding_transcript_exon_variant | 2/12 | 1 | ||||
AXL | ENST00000594880.1 | n.129G>A | non_coding_transcript_exon_variant | 2/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000269 AC: 6AN: 222864Hom.: 0 AF XY: 0.0000166 AC XY: 2AN XY: 120768
GnomAD4 exome AF: 0.0000152 AC: 22AN: 1446208Hom.: 0 Cov.: 31 AF XY: 0.0000139 AC XY: 10AN XY: 718276
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.112G>A (p.V38M) alteration is located in exon 2 (coding exon 2) of the AXL gene. This alteration results from a G to A substitution at nucleotide position 112, causing the valine (V) at amino acid position 38 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at